⌘K

Login Start Free

Home/Filings/4/0001645113-23-000008

4//SEC Filing

Shah Pritesh 4

Accession 0001645113-23-000008

CIK 0001645113other

View on SEC.gov Company Profile

Filed

Jan 8, 7:00 PM ET

Accepted

Jan 9, 6:20 PM ET

Size

4.7 KB

Accession

0001645113-23-000008

Insider Transaction Report

Form 4

Period: 2023-01-05

NovoCure LtdNVCR

Chief Commercial Officer

Transactions

Sale
Ordinary Shares
2023-01-05$108.00/sh−387$41,796→ 82,843 total

Footnotes (1)

[F1]Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Shah.

Documents

1 file

4
wf-form4_167330639201251.xmlPrimary
FORM 4

Issuer

NovoCure Ltd

CIK 0001645113

Entity typeother

Related Parties

1

filerCIK 0001744884

Filing Metadata

Form type: 4
Filed: Jan 8, 7:00 PM ET
Accepted: Jan 9, 6:20 PM ET
Size: 4.7 KB

View on SEC.gov